Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Cochlear shares were on track for their worst session in five years on Friday, after the Australian hearing implants maker reported first-half profit below estimates and forecast annual earnings at ...

Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has announced the expansion of its patent portfolio with ...

Statutory net profit up 7% to $205.1 millionInterim dividend up 8% to $2.15 per share vs. Morgans estimates of $2.18 (1.3% ...